NINA E. TOLKOFF-RUBIN, M.D.; ROBERT H. RUBIN, M.D., F.A.C.P.; EVELYN E. KELLER, M.A.; GEORGE P. BAKER, M.D., F.A.C.P.; JOHN A. STEWART, M.D.; MARTIN S. HIRSCH, M.D.
In a 12-month prospective study of cytomegalovirus infection on an acute hemodialysis unit, 10 of 80 patients (13%) and none of 26 staff developed active cytomegalovirus infection. Seven infections were coincidental with renal allograft rejection; three occurred 3 to 6 weeks after the transfusion of multiple units of conventional blood into seronegative patients. No person-to-person transmission was documented. In contrast to the effects of transfusing conventional blood, all 21 patients who entered dialysis without detectable cytomegalovirus antibody and received 2 to 10 U of frozen deglycerolyzed erythrocytes (total of 157 U) remained seronegative. Transmission of cytomegalovirus infection with transfusion with conventional blood is probably secondary to passage of leukocyte-borne virus that is lost during the freezing and deglycerolization procedure. Frozen erythrocytes prepared by cytoagglomeration procedures appear to be free of viable leukocytes and appear to carry a minimal risk of transmitting cytomegalovirus infection.
TOLKOFF-RUBIN NE, RUBIN RH, KELLER EE, BAKER GP, STEWART JA, HIRSCH MS. Cytomegalovirus Infection in Dialysis Patients and Personnel. Ann Intern Med. ;89:625–628. doi: 10.7326/0003-4819-89-5-625
Download citation file:
Published: Ann Intern Med. 1978;89(5_Part_1):625-628.
Infectious Disease, Nephrology, Renal Replacement Therapy.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use